SastiMedic
Flunil 40 mg Capsule 10s

Flunil 40 mg Capsule 10s

MRP: ₹58.24

Packaging

10 CAP

Composition

Fluoxetine 40mg

Company

INTAS

Buy Now

Substitutes for Flunil 40 mg Capsule 10s

Medicine Company Price You Save
F-tin 40mg Tablet 10s A N Pharmacia Laboratories ₹61.00

Side Effects of Flunil 40 mg Capsule 10s

Nervousness, insomnia, anxiety, headache, tremor, drowsiness, dry mouth, nausea, vomiting, sweating, diarrhoea. Seizures, mania, hypomania or mixed manic states reported. Hyponatraemia; elevation of hepatic enzymes. Potentially Fatal: Rarely, systemic events possibly related to vasculitis have been reported in patients with rash but may be serious involving lungs, kidney and liver.

Drug Interactions

May cause transient shift in plasma conc of tightly protein bound drugs e.g. warfarin and digoxin, resulting in adverse effects. T1/2 of diazepam is prolonged. Avoid concurrent use with clopidogrel. Potentially Fatal: Serious reactions when combined with MAOIs; at least 14 days should elapse after MAOIs withdrawal before starting fluoxetine treatment or at least 5 wk should elapse after fluoxetine treatment before starting MAOIs therapy. Two-fold increase in plasma levels of other antidepressants when combined with fluoxetine. Monitor lithium levels when combined.

Contraindications

Severe renal or hepatic failure; hypersensitivity; lactation; concomitant MAOIs or within 2 wk of MAOI withdrawal.

Mechanism of Action

Fluoxetine is a potent and highly selective inhibitor of serotonin (5-HT) re-uptake. No affinity for adrenoceptors or histamine, GABA-B, or muscarinic receptors. Absorption: Oral admin: Readily absorbed from the GI tract; peak plasma concentrations after 6-8 hr. Distribution: Widely distributed; enters breast milk. Protein-binding: 95%. Metabolism: Extensively hepatic by demethylation to norfluoxetine. Excretion: Urine. Elimination half-life: 1-3 days (fluoxetine), 4-16 days (norfluoxetine).

Special Precautions

Unstable epilepsy, liver and renal impairment, cardiac disease, diabetes, electroconvulsive therapy, bleeding disorders, closed-angle glaucoma; pregnancy. May impair performace of skilled tasks; withdraw gradually. Close monitoring of clinical worsening and behavioural changes during the 1st few mth of treatment or when there are dose changes.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by INTAS

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist